Stockreport

MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer

MAIA Biotechnology, Inc.  (MAIA) 
PDF THIO’s favorable disease control and overall response rates exceed reported standard-of-care data in third line treatment CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology [Read more]